Ishita Drugs and Industries has informed that it enclosed certificate received from Meenu Maheshwari, Practicing Company Secretary pursuant to the Regulation 40(9) and 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the year ended 31st March, 2023.
The above information is a part of company’s filings submitted to BSE.